Letter | 2020-11-27 |
Label | 2020-11-30 |
Review | 2020-12-23 |
Label | 2022-06-16 |
Letter | 2022-06-17 |
NDA 213793 | RHYTHM PHARMACEUTICALS INC |
Prescription | 001 |
001 | SOLUTION;SUBCUTANEOUS | 10MG/ML | 2 | IMCIVREE | SETMELANOTIDE |
TYPE 1; Type 1 - New Molecular Entity | ORIG | 1 | AP | 2020-11-25 | PRIORITY |
ORIG | 1 | Null | 6 |
001 | Prescription | TBD |
cder:Array ( [0] => Array ( [ApplNo] => 213793 [companyName] => RHYTHM PHARMACEUTICALS INC [docInserts] => ["",""] [products] => [{"drugName":"IMCIVREE","activeIngredients":"SETMELANOTIDE","strength":"10MG\/ML","dosageForm":"SOLUTION;SUBCUTANEOUS","marketingStatus":"Prescription","te":"","rld":"TBD","rs":"No"}] [labels] => [{"actionDate":"11\/25\/2020","submission":"ORIG-1","supplementCategories":"Approval","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2020\\\/213793s000lbl.pdf\"}]","notes":""}] [originalApprovals] => [{"actionDate":"11\/25\/2020","submission":"ORIG-1","actionType":"Approval","submissionClassification":"Type 1 - New Molecular Entity","reviewPriority":"PRIORITY; Orphan","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2020\\\/213793s000lbl.pdf\"},{\"name\":\"Letter (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/appletter\\\/2020\\\/213793Orig1s000ltr.pdf\"}]","notes":">"}] [supplements] => [actionDate] => 2020-11-25 ) )